# Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients

> **NCT06777511** · — · NOT_YET_RECRUITING · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Amputation
- Osseointegration

## Interventions

- **DRUG:** 5-aminolevulinic acid (5-ALA)
- **DEVICE:** Photodynamic therapy (PDT)

## Key facts

- **NCT ID:** NCT06777511
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-28
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06777511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06777511, "Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06777511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*